These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33660801)

  • 21. Curcumin and paclitaxel induce cell death in breast cancer cell lines.
    Calaf GM; Ponce-Cusi R; Carrión F
    Oncol Rep; 2018 Oct; 40(4):2381-2388. PubMed ID: 30066930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two Novel Tri-Aryl Derivatives Attenuate the Invasion-Promoting Effects of Stromal Mesenchymal Stem Cells on Breast Cancer.
    Moradi K; Barneh F; Irian S; Amini M; Moradpoor R; Amanzadeh A; Choopani S; Rahimi H; Ghodselahi T; Boujar MM; Salimi M
    Anticancer Agents Med Chem; 2019; 19(8):1002-1011. PubMed ID: 30747082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
    Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
    Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Effects of Aminonaphthoquinone Derivatives in Combination with Curcumin Against ER-positive Breast Cancer and Related Tumours.
    Pereira MC; Mohammed R; VAN Otterlo WAL; DE Koning CB; Davids H
    Anticancer Res; 2017 Dec; 37(12):6749-6759. PubMed ID: 29187453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of gefitinib‑celecoxib combination therapy in docetaxel‑resistant prostate cancer.
    Lin JZ; Hameed I; Xu Z; Yu Y; Ren ZY; Zhu JG
    Oncol Rep; 2018 Oct; 40(4):2242-2250. PubMed ID: 30066906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines.
    Buzharevski A; Paskas S; Sárosi MB; Laube M; Lönnecke P; Neumann W; Mijatovic S; Maksimovic-Ivanic D; Pietzsch J; Hey-Hawkins E
    ChemMedChem; 2019 Feb; 14(3):315-321. PubMed ID: 30602073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.
    Lin WL; Lee YJ; Wang SM; Huang PY; Tseng TH
    Eur J Pharmacol; 2012 Apr; 680(1-3):8-15. PubMed ID: 22329896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells.
    Abdallah FM; Helmy MW; Katary MA; Ghoneim AI
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of celecoxib on the proliferation and ultrastructural changes of MDA-MB-231 breast cancer cells.
    Ma Q; Gao Y; Wei DF; Jiang NH; Ding L; He X; Wei L; Zhang JW
    Ultrastruct Pathol; 2018; 42(3):289-294. PubMed ID: 29668331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of COX-2 in celecoxib-resistant breast cancer cell lines.
    Singh B; Irving LR; Tai K; Lucci A
    J Surg Res; 2010 Oct; 163(2):235-43. PubMed ID: 20691996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
    Liu Q; Loo WT; Sze SC; Tong Y
    Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib and LLW-3-6 Reduce Survival of Human Glioma Cells Independently and Synergistically with Sulfasalazine.
    Yerokun T; Winfield LL
    Anticancer Res; 2015 Dec; 35(12):6419-24. PubMed ID: 26637851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.
    Bocca C; Bozzo F; Bassignana A; Miglietta A
    Mol Cell Biochem; 2011 Apr; 350(1-2):59-70. PubMed ID: 21140284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling.
    Kumar BN; Rajput S; Dey KK; Parekh A; Das S; Mazumdar A; Mandal M
    BMC Cancer; 2013 Jun; 13():273. PubMed ID: 23731702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Super Magnetic Niosomal Nanocarrier as a New Approach for Treatment of Breast Cancer: A Case Study on SK-BR-3 and MDA-MB-231 Cell Lines.
    Jamshidifar E; Eshrati Yeganeh F; Shayan M; Tavakkoli Yaraki M; Bourbour M; Moammeri A; Akbarzadeh I; Noorbazargan H; Hossein-Khannazer N
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells.
    Suh YJ; Chada S; McKenzie T; Liu Y; Swisher SG; Lucci A; Hunt KK
    Surgery; 2005 Sep; 138(3):422-30. PubMed ID: 16213894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
    Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
    Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
    Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y
    Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
    El-Sayed NA; Nour MS; Salem MA; Arafa RK
    Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter to Editor on the paper entitled "Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer".
    Giacomini I; Quagliariello V; Ragazzi E; Montopoli M
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6174-6175. PubMed ID: 34730196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.